Skip to content

13F-HR filed by Yu Fan

Yu Fan filed this 13F-HR for the quarter ended 2024-06-30, filed 2024-08-14, with 6 holding rows worth $76,530,244.

Accession
0000950123-24-008418
Filed
2024-08-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2024

A combination report, 6 entries on the cover page, a total value of $76,530,244 stated on the cover page (in dollars after the unit check, H1), rows summing to $76,530,244 with VALUE read as dollars as filed, 13F file number 028-20833. The quarter's positions are built on this report. The resolved quarter.

Other managers

  • reports for this filerABG Innovation Capital Partners III GP Limited 028-20837
  • reports for this filerAlly Bridge Group (NY) LLC 028-20834

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
CG ONCOLOGY INC156944100COMMON STOCK1,578,344$49,828,320dollars as filed
CARGO THERAPEUTICS INC COM14179K101Stock912,000$14,975,040dollars as filed
ALUMIS INC022307102COM789,618$10,501,919dollars as filed
CASTLE BIOSCIENCES INC14843C105COMMON STOCK36,747$799,982dollars as filed
PYXIS ONCOLOGY INC COMMON STOCK747324101Stock69,303$229,393dollars as filed
SAGIMET BIOSCIENCES INC A786700104COMMON STOCK57,190$195,590dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000950123-24-008418this filing2024-08-14acceptance time not in the bulk data set